Home / People / Elizabeth-Anne Larsen
Portrait ofElizabeth-Anne Larsen

Elizabeth-Anne Larsen

Senior Associate
Solicitor Advocate

Contact
CMS Cameron McKenna Nabarro Olswang LLP
Cannon Place
78 Cannon Street
London
EC4N 6AF
United Kingdom
Languages English

Elizabeth-Anne Larsen is a Senior Associate – Solicitor Advocate in CMS’ London office, specialising in litigation and regulatory, primarily in the fields of life sciences, product liability, consumer products, and healthcare.  Elizabeth-Anne is Co-Head of CMS’ Global Life Sciences & Healthcare Associates Group and Co-Head of the UK Life Sciences Associates Group.  

Elizabeth-Anne is dual-qualified in both the US (Texas) and England & Wales.  She has vast and unique experience in both jurisdictions in various matters of life sciences and healthcare law, including managing complex, large-scale multi-district litigation (US) and group litigation (UK) (“class actions”) and other product liability disputes involving medical device and pharmaceutical products; advising life sciences and consumer product companies on regulatory, compliance, and liability issues; and representing life sciences and healthcare companies at inquests.  She is active in the growing areas of class actions/group litigation and advises clients and lobby groups regarding strategies focused on reducing overall exposure, general defence, and impact of third-party litigation funding.

Elizabeth-Anne is also actively involved in UK and European trade associations in medical device, pharmaceutical, and biotech sectors, broadening the depth of perspective she can provide when advising global clients.

Elizabeth-Anne has given presentations on comparisons of product liability in the US and UK, changes to EU product liability regime, transaction trends in the Life Sciences sector, and has co‑authored CMS expert guides and podcast scripts relating to digital health/telemedicine for CMS’ On the Pulse podcasts.  She has recently presented on product liability/product regulation at both webinars and law conferences.   

Elizabeth-Anne’s experience in both the US and the UK provides exceptional, dimensional perspective relevant and pivotal to global clients.

more less

"Elizabeth-Anne is a rising star in the field. She has an impressive and varied caseload… She is a real stakhanovite – but however hard she works, there is always a smile on her face."

Legal 500, Life Sciences 2022

Relevant experience

  • A global pharmaceutical company in defence of product liability group litigation (class action) across multiple UK jurisdictions relating to an implantable medical device that has been the source of litigation internationally, requiring close coordination across multiple jurisdictions globally.
  • A global medical device company in defence of product liability claims relating to cardiac device malfunction, leading to catastrophic injuries to a UK patient.
  • UK innovator digital health manufacturer on its product liability exposure and risk management strategy associated with AI-driven tools for detection of skin cancers.
  • A global medical device company in defence of potential product liability group litigation following a product recall.
  • An international vaccines manufacturer regarding practical implications of GDP regulatory wholesale-dealing requirements relating to customer qualification for medicinal products and possible refusal to supply.
  • Global tech/consumer products company regarding potential liability and regulatory requirements for innovative smart retailing equipment when used for medicinal product retailing.
more less

Memberships & Roles

  • ABHI.
  • Biotech Industry Association.
  • European Justice Forum.
  • Fair Civil Justice Forum.
more less

Lectures list

  • 2018 - To Be or Not to Be (a Privilege)—That is the Question!
more less

Education

  • 2000 – J.D., Southern Methodist University, Dallas, Texas (USA)
more less

Feed

18/12/2023
Digital health apps and telemedicine in England and Wales
Digital Health Apps/Software 1. How is the software within digital health apps classified in your jurisdiction, and what regulation(s) apply? 1.1 Is it considered a “medical device,” and if so...
Comparable
23/03/2023
On the Pulse webinar series 2023 - Spring
Welcome to the launch of the On the Pulse webinar series
29/06/2021
In View: Life Sciences quarterly update webinar
CMS are delighted to invite you to the next instalment of our Life Sciences quarterly update webinar where CMS experts across the firm will discuss key industry topics impacting, innovating and disrupting...
30/01/2018
Privilege - Future Leaders Session
We would be Privileged if you would join us for our inaugural practical seminar for future legal leaders in the life sciences and healthcare sector. This seminar is the first in a series of practical...